Premium
Placental Interleukin‐15 Expression in Recurrent Miscarriage
Author(s) -
Toth Bettina,
Haufe Thomas,
Scholz Christoph,
Kuhn Christina,
Friese Klaus,
Karamouti Maria,
Makrigiannakis Antonis,
Jeschke Udo
Publication year - 2010
Publication title -
american journal of reproductive immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.071
H-Index - 97
eISSN - 1600-0897
pISSN - 1046-7408
DOI - 10.1111/j.1600-0897.2010.00879.x
Subject(s) - decidua , miscarriage , trophoblast , immunohistochemistry , andrology , recurrent miscarriage , placenta , cytokine , real time polymerase chain reaction , medicine , fetus , pregnancy , biology , immunology , biochemistry , genetics , gene
Citation Toth B, Haufe T, Scholz C, Kuhn C, Friese K, Karamouti M, Makrigiannakis A, Jeschke U. Placental Interleukin‐15 expression in recurrent miscarriage. Am J Reprod Immunol 2010; 64: 402–410 Problem Cytokines play a fundamental role at the feto–maternal interface. A dysregulation of the cytokine profile could be linked with fetal rejection. This study investigated differences in the expression of the Th1 cytokine interleukin‐15 (IL‐15) of normal and disturbed pregnancy. Method of study Analysis of IL‐15 expression by immunohistochemistry and real‐time RT‐PCR in placental tissue from normal pregnancies, spontaneous miscarriage and recurrent miscarriage (RM) was performed. Results Expression of IL‐15 was upregulated on mRNA and protein level in the placenta of miscarriage patients, especially in patients with RM. Immunohistochemistry and immunofluorescence double staining revealed extravillous trophoblast cells (EVT) as IL‐15‐expressing cells. Staining results were confirmed by real‐time PCR (TaqMan). Conclusion Increased expression of IL‐15 in the decidua of patients with RM may be linked to disturbed implantation and vascularization with consecutive placental and fetal rejection.